Does the surge in coronavirus infections in Europe warrant a more defensive strategy? Not necessarily. Portfolio manager, Nik Dvornak sheds light on why taking a three-year plus view on Europe can present patient investors with opportunities, including many high-innovation companies in global healthcare, travel, luxury brands and retail.